Results
Senores Pharmaceuticals Reports 108% PAT Growth in FY26
Senores Pharmaceuticals reported consolidated revenue growth of 63% to ₹680 Cr and PAT surge of 108% to ₹122 Cr, driven by regulated markets and portfolio expansion.
The company completed strategic ac
